WO2001068140A3 - Opioid formulations - Google Patents
Opioid formulations Download PDFInfo
- Publication number
- WO2001068140A3 WO2001068140A3 PCT/US2001/006955 US0106955W WO0168140A3 WO 2001068140 A3 WO2001068140 A3 WO 2001068140A3 US 0106955 W US0106955 W US 0106955W WO 0168140 A3 WO0168140 A3 WO 0168140A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formulations
- fentanyl
- concentration
- subject
- further provides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001243414A AU2001243414B2 (en) | 2000-03-10 | 2001-03-02 | Opioid formulations |
AU4341401A AU4341401A (en) | 2000-03-10 | 2001-03-02 | Opioid formulations |
JP2001566703A JP4969009B2 (en) | 2000-03-10 | 2001-03-02 | Opioid formulation |
US10/220,525 US7074803B2 (en) | 2001-03-02 | 2001-03-02 | Opioid formulations |
CA002402865A CA2402865A1 (en) | 2000-03-10 | 2001-03-02 | Opioid formulations |
US10/188,325 US6835194B2 (en) | 1999-03-18 | 2002-06-27 | Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners |
US10/922,239 US20050106205A1 (en) | 1999-03-18 | 2004-08-18 | Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners |
US13/355,217 US20120239007A1 (en) | 1999-03-18 | 2012-01-20 | Implantable Devices and Methods for Treatment of Pain by Delivery of Fentanyl and Fentanyl Congeners |
US14/260,181 US20140350053A1 (en) | 2000-03-10 | 2014-04-23 | Opioid formulations |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18826300P | 2000-03-10 | 2000-03-10 | |
US60/188,263 | 2000-03-10 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/522,535 Continuation-In-Part US6541021B1 (en) | 1999-03-18 | 2000-03-10 | Devices and methods for pain management |
Related Child Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/220,525 A-371-Of-International US7074803B2 (en) | 2000-03-10 | 2001-03-02 | Opioid formulations |
PCT/US2001/043143 Continuation-In-Part WO2002043800A2 (en) | 1999-03-18 | 2001-11-21 | Devices and methods for controlled delivery from a drug delivery device |
US10/188,325 Continuation-In-Part US6835194B2 (en) | 1999-03-18 | 2002-06-27 | Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners |
US11/477,140 Continuation US20070014820A1 (en) | 2000-03-10 | 2006-06-27 | Opioid formulations |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001068140A2 WO2001068140A2 (en) | 2001-09-20 |
WO2001068140A3 true WO2001068140A3 (en) | 2001-12-13 |
Family
ID=22692427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/006955 WO2001068140A2 (en) | 1999-03-18 | 2001-03-02 | Opioid formulations |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP4969009B2 (en) |
AU (2) | AU2001243414B2 (en) |
CA (1) | CA2402865A1 (en) |
WO (1) | WO2001068140A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0300531D0 (en) | 2003-01-10 | 2003-02-12 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
US8940311B2 (en) * | 2004-10-21 | 2015-01-27 | Tae-Hong Lim | In situ controlled release drug delivery system |
US20140179740A1 (en) * | 2012-12-21 | 2014-06-26 | Mylan Inc. | Stable liquid remifentanil formulations |
JP6081240B2 (en) * | 2013-03-13 | 2017-02-15 | テルモ株式会社 | Remifentanil injection |
WO2016038734A1 (en) | 2014-09-12 | 2016-03-17 | テルモ株式会社 | Remifentanil injection |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4588580A (en) * | 1984-07-23 | 1986-05-13 | Alza Corporation | Transdermal administration of fentanyl and device therefor |
WO1990007333A1 (en) * | 1989-01-06 | 1990-07-12 | Riker Laboratories, Inc. | Fentanyl containing aerosol compositions |
WO1997049402A1 (en) * | 1996-06-27 | 1997-12-31 | Janssen Pharmaceutica N.V. | Sustained release sufentanil compositions |
US5910301A (en) * | 1994-05-13 | 1999-06-08 | Aradigm Corporation | Method of intrapulmonary administration of a narcotic drug |
WO2000054745A2 (en) * | 1999-03-18 | 2000-09-21 | Durect Corporation | Devices and methods for pain management |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA856002B (en) * | 1984-08-10 | 1987-04-29 | Du Pont | Transdermal delivery of opioids |
JPH05331064A (en) * | 1992-05-26 | 1993-12-14 | Sekisui Chem Co Ltd | Anti-inflammatory analgesic plaster |
JPH07206903A (en) * | 1994-01-24 | 1995-08-08 | Takeda Chem Ind Ltd | Aggregate of super molecule structure type |
JPH09176000A (en) * | 1995-12-28 | 1997-07-08 | Teijin Ltd | Plaster for medical use |
-
2001
- 2001-03-02 AU AU2001243414A patent/AU2001243414B2/en not_active Ceased
- 2001-03-02 AU AU4341401A patent/AU4341401A/en active Pending
- 2001-03-02 WO PCT/US2001/006955 patent/WO2001068140A2/en active IP Right Grant
- 2001-03-02 CA CA002402865A patent/CA2402865A1/en not_active Abandoned
- 2001-03-02 JP JP2001566703A patent/JP4969009B2/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4588580A (en) * | 1984-07-23 | 1986-05-13 | Alza Corporation | Transdermal administration of fentanyl and device therefor |
US4588580B1 (en) * | 1984-07-23 | 1989-01-03 | ||
US4588580B2 (en) * | 1984-07-23 | 1999-02-16 | Alaz Corp | Transdermal administration of fentanyl and device therefor |
WO1990007333A1 (en) * | 1989-01-06 | 1990-07-12 | Riker Laboratories, Inc. | Fentanyl containing aerosol compositions |
US5910301A (en) * | 1994-05-13 | 1999-06-08 | Aradigm Corporation | Method of intrapulmonary administration of a narcotic drug |
WO1997049402A1 (en) * | 1996-06-27 | 1997-12-31 | Janssen Pharmaceutica N.V. | Sustained release sufentanil compositions |
WO2000054745A2 (en) * | 1999-03-18 | 2000-09-21 | Durect Corporation | Devices and methods for pain management |
Non-Patent Citations (2)
Title |
---|
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1995, RAMSAY E C ET AL: "Immobilization of black bears (Ursus americanus) with orally administered carfentanil citrate.", XP002175618, Database accession no. PREV199598404995 * |
JOURNAL OF WILDLIFE DISEASES, vol. 31, no. 3, 1995, pages 391 - 393, ISSN: 0090-3558 * |
Also Published As
Publication number | Publication date |
---|---|
AU2001243414B2 (en) | 2005-05-19 |
AU4341401A (en) | 2001-09-24 |
JP2003526680A (en) | 2003-09-09 |
JP4969009B2 (en) | 2012-07-04 |
CA2402865A1 (en) | 2001-09-20 |
WO2001068140A2 (en) | 2001-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002015903A3 (en) | Novel pharmaceutical composition for administering n-0923 | |
WO2005065319A3 (en) | Generally linear effervescent oral fentanyl dosage form and methods of administering | |
EP1708685A4 (en) | Effervescent oral opiate dosage forms and methods of administering opiates | |
MXPA04004837A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. | |
MXPA04004842A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. | |
TW200605870A (en) | Topical methadone compositions and methods for using the same | |
IL161154A0 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
WO2004043363A8 (en) | Protein-stabilized liposomal formulations of pharmaceutical agents | |
WO2003030829A3 (en) | Liposome-encapsulated insulin formulations | |
IL179718A0 (en) | Pharmaceutical composition containing irbesartan | |
SE0102276D0 (en) | Device and method for administering a drug | |
WO2003045306A3 (en) | Phenoxy amine compounds and compositions for delivering active agents | |
IL136591A (en) | Nasal pharmaceutical solutions | |
WO2000050046A8 (en) | Stabilized oral pharmaceutical composition containing iodide and iodate and method | |
MXPA03007857A (en) | Compounds and compositions for delivering active agents. | |
WO2000078294A3 (en) | Oral administration form for administering a fixed tramadol and diclofenac combination | |
WO2002070524A3 (en) | N-but-3-enyl norbuprenorphine and its use as analgesic | |
RS44204A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
MXPA06000332A (en) | Novel solid pharmaceutical composition comprising amisulpride. | |
IL179177A (en) | Pharmaceutical composition comprising acyclovir and a delivery agent, a dosage unit, use of acyclovir in the preparation of the pharmaceutical composition, use of the pharmaceutical composition in the preparation of a medicament and a method of preparing the pharmaceutical composition | |
WO2001068140A3 (en) | Opioid formulations | |
AU9731198A (en) | Histogranin peptide and their analgesic use | |
RS44304A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
TW200611697A (en) | Generally linear effervescent oral fentanyl dosage form and methods of administering | |
MY134019A (en) | Aryl oxime-piperazines useful as ccr5 antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001243414 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 566703 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2402865 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10220525 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase | ||
WWG | Wipo information: grant in national office |
Ref document number: 2001243414 Country of ref document: AU |